Comparing Osteoporosis Medications for Safety and Effectiveness
Official title: Comparative Effectiveness and Safety of Osteoporosis Drug Therapies
Funded at Mayo Clinic Rochester · NIH-11129725 · Data updated 2026-11-12
This project helps us understand which osteoporosis medications work best and are safest for people at risk of broken bones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 15, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $810,627 |
| NIH project number | 5R01AG079113-04 |
| Project ID | NIH-11129725 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is relevant for adults, especially those 65 and older, who are at risk of osteoporotic fractures and are considering or currently using osteoporosis drug therapies.
✕Less likely to help
Patients who do not have osteoporosis or are not candidates for drug therapy would not directly benefit from this specific research.
What this research studies
Many people face the risk of broken bones due to osteoporosis, but concerns about long-term medication side effects can make it hard to stick with treatment. This project looks closely at different osteoporosis medications to see how well they prevent fractures over time and if they cause rare side effects like atypical femur fracture or jaw bone issues. We want to learn if taking breaks from medication or switching treatments can reduce these risks without making the medication less effective. The goal is to provide clearer information so patients and doctors can make better choices about long-term bone health.
Why it matters
Potential benefit: If successful, this work could help patients and doctors make more informed decisions about osteoporosis treatment, potentially leading to better fracture prevention and fewer side effects.
How similar studies have gone: While large trials have shown osteoporosis drugs reduce fracture risk, there is less evidence on the long-term effectiveness and safety of specific strategies like drug holidays or sequential therapies.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: Brito Campana, Juan P — Mayo Clinic Rochester
- Study coordinator: Brito Campana, Juan P
Related research
Other NIH-funded projects on the same topics.
-
Or olive-oil derived compound to prevent bone loss in women
A safe, orally taken nutraceutical may help prevent osteoporosis in adult women by supporting bone formation and reducing bone loss.
-
When to stop, switch, or pause long-term osteoporosis medicines for older adults
This project looks at whether stopping, switching, or taking breaks from long-term osteoporosis drugs changes fracture risk and side effects for older adults.
-
Cortical Bone Mechanics Technology to better screen for osteoporosis
A new noninvasive test called CBMT uses ulnar flexural rigidity to predict fracture risk better than standard bone density tests, helping adults who may be at risk for osteoporosis.
-
Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women
A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.
-
Metabolomics clues to osteoporosis risk in diverse populations
A study using small molecules in blood samples to understand osteoporosis risk, with a focus on aging, ethnicity, and sex differences.
-
Single-Cell Study of Bone Cells to Understand Osteoporosis
Researchers will study individual bone-related cells from people to uncover why aging leads to weaker bones and higher fracture risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.